ADMA logo

ADMA Biologics (ADMA) Current Assets

Annual Current Assets

$257.01 M
-$13.39 M-4.95%

31 December 2023

ADMA Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$318.19 M
+$14.50 M+4.78%

30 September 2024

ADMA Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+23.8%
3 y3 years+23.1%+52.4%
5 y5 years+199.5%+270.8%

ADMA Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-5.0%+23.1%at high+52.4%
5 y5 years-5.0%+199.5%at high+270.8%
alltimeall time-5.0%>+9999.0%at high>+9999.0%

ADMA Biologics Current Assets History

DateAnnualQuarterly
Sept 2024
-
$318.19 M(+4.8%)
June 2024
-
$303.69 M(+9.9%)
Mar 2024
-
$276.42 M(+7.6%)
Dec 2023
$72.17 M(-7.5%)
$257.01 M(-6.1%)
Sept 2023
-
$273.70 M(+2.8%)
June 2023
-
$266.24 M(+0.8%)
Mar 2023
-
$264.09 M(-2.3%)
Dec 2022
$78.06 M(+15.6%)
$270.40 M(+20.7%)
Sept 2022
-
$224.09 M(+0.6%)
June 2022
-
$222.77 M(-7.1%)
Mar 2022
-
$239.80 M(+14.9%)
Dec 2021
$67.52 M(+25.2%)
$208.73 M(+19.4%)
Sept 2021
-
$174.79 M(+2.0%)
June 2021
-
$171.36 M(-3.3%)
Mar 2021
-
$177.28 M(+15.3%)
Dec 2020
$53.93 M(+30.7%)
$153.74 M(+10.2%)
Sept 2020
-
$139.55 M(-2.4%)
June 2020
-
$142.99 M(-13.6%)
Mar 2020
-
$165.49 M(+92.8%)
Dec 2019
$41.27 M(-6.9%)
$85.82 M(-11.8%)
Sept 2019
-
$97.32 M(-6.3%)
June 2019
-
$103.89 M(+171.0%)
Mar 2019
-
$38.33 M(-13.9%)
Dec 2018
$44.35 M(-2.9%)
$44.53 M(-28.8%)
Sept 2018
-
$62.50 M(-15.1%)
June 2018
-
$73.63 M(+58.6%)
Mar 2018
-
$46.42 M(-25.5%)
Dec 2017
$45.68 M
$62.34 M(+98.3%)
Sept 2017
-
$31.44 M(-29.0%)
DateAnnualQuarterly
June 2017
-
$44.27 M(+182.3%)
Mar 2017
-
$15.68 M(-27.6%)
Dec 2016
$2.03 M(-16.3%)
$21.66 M(-14.6%)
Sept 2016
-
$25.36 M(-14.0%)
June 2016
-
$29.49 M(+69.9%)
Mar 2016
-
$17.36 M(-18.5%)
Dec 2015
$2.42 M(-17.4%)
$21.29 M(-15.6%)
Sept 2015
-
$25.24 M(-7.0%)
June 2015
-
$27.13 M(-12.4%)
Mar 2015
-
$30.98 M(+28.6%)
Dec 2014
$2.94 M(+216.5%)
$24.09 M(+6.7%)
Sept 2014
-
$22.57 M(-14.8%)
June 2014
-
$26.49 M(-13.9%)
Mar 2014
-
$30.79 M(-0.9%)
Dec 2013
$927.50 K(-42.3%)
$31.05 M(+334.7%)
Sept 2013
-
$7.14 M(-22.1%)
June 2013
-
$9.17 M(-25.5%)
Mar 2013
-
$12.31 M(-11.8%)
Dec 2012
$1.61 M(>+9900.0%)
$13.95 M(+16.4%)
Sept 2012
-
$11.98 M(-18.0%)
June 2012
-
$14.62 M(-7.7%)
Mar 2012
-
$15.84 M(>+9900.0%)
Dec 2011
-
$8100.00(+37.3%)
Sept 2011
-
$5900.00(-30.6%)
June 2011
$0.00(0.0%)
$8500.00(-47.5%)
Mar 2011
-
$16.20 K(+422.6%)
Dec 2010
-
$3100.00(-74.2%)
June 2010
-
$12.00 K
June 2010
$0.00
-

FAQ

  • What is ADMA Biologics annual total current assets?
  • What is the all time high annual current assets for ADMA Biologics?
  • What is ADMA Biologics quarterly total current assets?
  • What is the all time high quarterly current assets for ADMA Biologics?
  • What is ADMA Biologics quarterly current assets year-on-year change?

What is ADMA Biologics annual total current assets?

The current annual current assets of ADMA is $257.01 M

What is the all time high annual current assets for ADMA Biologics?

ADMA Biologics all-time high annual total current assets is $270.40 M

What is ADMA Biologics quarterly total current assets?

The current quarterly current assets of ADMA is $318.19 M

What is the all time high quarterly current assets for ADMA Biologics?

ADMA Biologics all-time high quarterly total current assets is $318.19 M

What is ADMA Biologics quarterly current assets year-on-year change?

Over the past year, ADMA quarterly total current assets has changed by +$61.18 M (+23.80%)